Achieve Life Sciences, Inc. (ACHV) Dividend History

Achieve Life Sciences, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for the treatment of smoking cessation and other neuropsychiatric conditions. The company is known for its research and development efforts in psychedelics and innovative medications aimed at addressing addiction and mental health issues.

22722 29th Dr. Se, Seattle, WA, 98021
Phone: 425-686-1500
Website: https://www.achievelifesciences.com

Dividend History

Achieve Life Sciences, Inc. currently does not pay dividends

Company News

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Achieve Life Sciences reported financial results for Q4 and full-year 2024, highlighting key milestones in the cytisinicline development program, including completion of enrollment in the ORCA-OL trial and positive DSMC reviews. The company reiterated plans to submit the cytisinicline NDA by the end of Q2 2025.

GlobeNewswire Inc.
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

Achieve Life Sciences has promoted Jaime Xinos to Chief Commercial Officer to oversee the commercial operations and strategic preparations for the anticipated U.S. launch of cytisinicline, a treatment for nicotine dependence.

GlobeNewswire Inc.
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced data from the Phase 2 ORCA-V1 vaping cessation trial will be presented today, Friday, May 17, 2024, at the Society of General Internal Medicine (SGIM) Annual Meeting being held in Boston, MA.

GlobeNewswire Inc.
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Company to host conference call at 4:30 PM EDT today, Thursday, May 9, 2024 Company to host conference call at 4:30 PM EDT today, Thursday, May 9, 2024

GlobeNewswire Inc.
Rare Stock Picks In April 2024 - From 28 Discerning Analysts

The following new investment ideas were made by analysts who have NO OTHER Buy/Strong Buy recommendations in the past 3 months. Check out the picks for April 2024.

Seeking Alpha

Featured Companies: AAPL ADM AMRK BBW CHDN FLNC FOUR HASI IRDM MA MPW NFLX ORLY OXY PD SAMG SHLS SLS SSTI WBD XLE ZENV

Dividend data last updated 06/06/2025 21:24:44 UTC